Anxo Pharmaceutical

Anxo Pharmaceutical is a Taiwan-based specialty pharmaceutical company focused on the development and manufacturing of high-barrier generic drugs and value-added medicines. The company specializes in complex formulation technologies, particularly Long-Acting Injectables (LAI) for the treatment of Central Nervous System (CNS) disorders such as schizophrenia and bipolar disorder. Anxo operates a PIC/S GMP-certified manufacturing facility in Hsinchu, Taiwan, providing CDMO services for global partners. Their business model integrates the commercialization of niche generics with the development of 505(b)(2) products aimed at international markets, including the United States, China, and Southeast Asia.